Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sequent Scientific Ltd updates on JV agreement with Shasun Pharmaceuticals


Friday, 11 Apr 2014 04:18am EDT 

Sequent Scientific Ltd:Says Alivira Animal Health Limited, Joint venture (JV) with Shasun Pharmaceuticals completed allotment of 7,400,000 equity shares to Shasun Pharmaceuticals Limited in consideration for the transfer of the Shasun's Vizag Unit.Also allotted 2,114,165 shares to Devicam Capital LLP, an enterprise jointly owned by the promoters of Shasun Pharmaceuticals Limited and Sequent Scientific Limited for cash. 

Company Quote

779.25
-10.5 -1.33%
3 Jul 2015